RCS-8

In this article, we will explore the fascinating world of RCS-8 and everything that this concept entails. RCS-8 is a topic that has captured the attention of countless individuals throughout history, generating great interest and debate in various areas. Over the years, RCS-8 has evolved and adapted to the changes of the modern world, demonstrating its relevance in today's society. Through this article, we will examine in detail the different aspects and perspectives related to RCS-8, with the aim of providing a broad and complete vision of this exciting topic.
RCS-8
Legal status
Legal status
Identifiers
  • 2-(2-Methoxyphenyl)-1-ethanone
CAS Number
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC25H29NO2
Molar mass375.512 g·mol−1
3D model (JSmol)
  • COc1ccccc1CC(=O)c2cn(c3c2cccc3)CCC4CCCCC4
  • InChI=1S/C25H29NO2/c1-28-25-14-8-5-11-20(25)17-24(27)22-18-26(23-13-7-6-12-21(22)23)16-15-19-9-3-2-4-10-19/h5-8,11-14,18-19H,2-4,9-10,15-17H2,1H3 checkY
  • Key:BSQFBMXCQIKYNI-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

RCS-8 (also known as 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole, SR-18, and BTM-8) is a synthetic cannabinoid that has been found as an ingredient of "herbal" synthetic cannabis blends. It can be described as an analogue of JWH-250 with the 1-pentyl group replaced by 1-(2-cyclohexylethyl), and can be expected to be less potent than JWH-250 (cf. JWH-007 and its cyclohexylethyl analogue). Despite not having been reported in the scientific or patent literature as yet, reputed recreational use of RCS-8 in the United States has led to it being specifically listed in a proposed 2011 amendment to the Controlled Substances Act, aiming to add a number of synthetic drugs into Schedule I. In addition, all CB1 receptor agonists of the 3-phenylacetylindole class such as RCS-8 are Schedule I Controlled Substances.

See also

References

  1. ^ Huffman JW, Dai D, Martin BR, Compton DR (1994). "Design, Synthesis and Pharmacology of Cannabimimetic Indoles". Bioorganic & Medicinal Chemistry Letters. 4 (4): 563–566. doi:10.1016/S0960-894X(01)80155-4.
  2. ^ Synthetic Drug Control Act of 2011
  3. ^ 21 U.S.C. § 812: Schedules of controlled substances